Biography
Katya Dajani is an associate in Weil’s Antitrust practice group, where she focuses on civil antitrust, class action, and other complex litigation, government investigations, and compliance counseling.
Katya’s recent experience includes representing a generic drugs manufacturer in an antitrust multidistrict litigation and representing a pharmaceutical company in its case against a competitor involving bundling.
Prior to law school, Katya served as an associate at a leading international economic consultancy. While in law school, Katya served as a legal extern with the New York State Attorney General’s Antitrust Bureau.
Katya received her J.D. from Columbia Law School, where she was a Harlan Fiske Stone Scholar, and a staff editor for the Columbia Journal of Transnational Law. She received her B.A. in International Relations, magna cum laude and Phi Beta Kappa, from Brown University.
Latest Thinking
Latest Thinking
- Weil Private Equity Sponsor Sync Publication — By Christopher R. Machera, Arnie Fridhandler, David B. Gail, Olivia J. Greer, Megan A. Granger, Adam C. Hemlock, Katya Dajani and Glenn D. West — PDF — January 2024
- FTC Challenges Alleged “Roll Up” and Other Anticompetitive Conduct by Sponsor and Portfolio Company Alert — Antitrust — By Adam C. Hemlock, Megan A. Granger and Katya Dajani — PDF — September 28, 2023